使用警語:中文譯文來源為 AI 翻譯,僅供參考,實際內容請以英文原文為主
Operator
Operator
Good day, everyone, and welcome to the Q1 2025 Knowles Corporation earnings call. This call is being recorded. At this time, I would like to hand things over to Ms. Sarah Cook. Please go ahead, ma'am.
各位大家好,歡迎參加 Knowles Corporation 2025 年第一季(Q1)財報電話會議。本次電話會議將被錄音。此刻,我想把時間交給 Sarah Cook 女士。請開始,女士。
Sarah Cook - Vice President, Investor Relations
Sarah Cook - Vice President, Investor Relations
Thank you and welcome to our first-quarter of 2025 earnings call. I'm Sarah Cook, Vice President of Investor Relations, and presenting with me today are Jeffrey Niew, our President and CEO; and John Anderson, our Senior Vice President and CFO.
謝謝,歡迎參加我們 2025 年第一季財報電話會議。我是投資人關係副總裁 Sarah Cook,今天與我一同出席的有:我們的總裁暨執行長 Jeffrey Niew,以及我們的資深副總裁暨財務長 John Anderson。
Our call today will include remarks about future expectations, plans, and prospects for Knowles, which constitute forward-looking statements for purposes of the Safe Harbor provisions under applicable federal securities laws.
今天的電話會議將包含關於 Knowles 未來預期、計畫與前景的說明,這些內容依適用之聯邦證券法「安全港」條款之目的,構成前瞻性陳述。
Forward-looking statements in this call will include comments about demand for company products, anticipated trends in company sales, expenses, and profits, and involve a number of risks and uncertainties that could cause actual results to differ materially from current expectations.
本次電話會議中的前瞻性陳述將包括對公司產品需求、公司銷售、費用與獲利之預期趨勢的評論,並涉及多項風險與不確定性,可能導致實際結果與目前預期出現重大差異。
The company urges investors to review the risks and uncertainties in the company's SEC filings, including but not limited to the annual report on Form 10-K for the fiscal year ended December 31, 2024, periodic reports filed from time to time with the SEC, and the risks and uncertainties identified in today's earnings release. All forward-looking statements are made as of date in this call, and Knowles disclaims any duty to update such statements except as required by law.
公司敦促投資人檢視公司向 SEC 提交之文件中的風險與不確定性,包括但不限於截至 2024 年 12 月 31 日止會計年度之 Form 10-K 年報、不時向 SEC 提交之定期報告,以及今日財報新聞稿中所辨識之風險與不確定性。所有前瞻性陳述均以本次電話會議當日為準,除法律要求外,Knowles 不承擔更新該等陳述之任何義務。
In addition, pursuant to Reg G, any non-GAAP financial measures referenced during today's conference call can be found in our press release posted on our website at knowles.com and in our current form -- in our current report on Form 8-K filed today with the SEC. This will include a reconciliation to the most directable, comparable GAAP measure.
此外,依據 Reg G,今日電話會議中提及之任何非 GAAP 財務衡量指標,皆可在我們發布於 knowles.com 網站之新聞稿,以及我們今日向 SEC 提交之 Form 8-K 當期報告中查閱。其中將包含與最直接且可比之 GAAP 指標的調節表。
All financial references on this call will be on a non-GAAP continuing operations basis unless otherwise indicated. We've made selected financial information available in webcast slides, which can be found in the Investor Relations section of our website.
除非另有說明,本次電話會議中所有財務數據皆以非 GAAP 的持續營運基礎呈現。我們已在網路直播簡報投影片中提供部分財務資訊,可於本公司網站之投資人關係(Investor Relations)專區取得。
With that, let me turn the call over to Jeff who will provide details on our results. Jeff.
接下來,我把電話交給 Jeff,由他說明我們的業績細節。Jeff。
Jeffrey Niew - President, Chief Executive Officer, Director
Jeffrey Niew - President, Chief Executive Officer, Director
Thanks, Sarah, and thanks to all of you for joining us today.
謝謝你,Sarah,也感謝各位今天加入我們。
Before I provide our commentary on the Q1 results and report on what we are seeing in our markets for Q2 and beyond, I would like to touch on the terror situation we are all hearing so much about.
在我針對第一季(Q1)業績發表評論,並說明我們對第二季(Q2)及之後市場的觀察之前,我想先談談大家最近聽到很多的恐怖情勢。
Obviously, there's a lot going on in the markets over the last few weeks. It has been and continues to be fluid, and while I'm being cautious about how it could impact our business, I believe Knowles is well positioned to continue to deliver growth in earnings and revenue despite the current tariff environment.
顯然,過去幾週市場發生了很多事情。情勢一直在變動且仍具流動性;雖然我對其可能對我們業務造成的影響保持審慎,但我相信即使在目前的關稅環境下,Knowles 仍具備良好定位,能持續實現獲利與營收成長。
The tariff situation can be easily explained by breaking things into three major areas that could affect Knowles. First and most simply, our direct tariff exposure that is our revenue that could be subject to tariffs. Generally speaking, Knowles is a proximity manufacturer, meaning the vast majority of product built in the US is shipped within the US, and product built in Asia ships to customers in Asia.
關稅情勢可透過拆解為三個可能影響 Knowles 的主要面向來簡要說明。第一,也是最直接的,是我們的直接關稅曝險,也就是可能被課徵關稅的營收。一般而言,Knowles 採取就近製造策略(proximity manufacturer),也就是在美國製造的絕大多數產品會在美國境內出貨,而在亞洲製造的產品則出貨給亞洲客戶。
Based on this proximity manufacturing strategy and our associated footprint, we estimate that less than 5% of revenue are subject to the current tariffs. In our markets of MedTech, Defense, and Industrial, our expectation is we can pass these tariffs on to our customers without significant loss of business.
基於此就近製造策略及相應的據點布局,我們估計目前關稅適用的營收占比低於 5%。在我們的醫療科技(MedTech)、國防與工業市場中,我們預期可將這些關稅轉嫁給客戶,而不會造成顯著的業務流失。
Second, there's an indirect tariff exposure or impact on our sourcing of raw materials for our different manufacturing locations. We have a world-class global supply chain team that, when possible, procures materials geographically close to our production facilities. We believe that less than 3% of our cost of goods sold will be impacted by current tariffs. We also anticipate being able to recover substantially all tariff impacts through price increases and surcharges.
第二,是間接關稅曝險,也就是對我們在不同製造據點採購原物料的影響。我們擁有世界級的全球供應鏈團隊,在可行時會就近於生產設施所在地採購材料。我們認為目前關稅影響的銷貨成本占比低於 3%。我們也預期能透過漲價與附加費回收幾乎所有關稅影響。
Finally, there's an impact on our customers and market demand. This is the most difficult to predict at this moment, and while no company will be immune to the effect of tariffs, I believe the markets we serve in MedTech, Defense, and Industrial sectors, will be relatively insulated from tariff impacts.
最後,是對我們客戶與市場需求的影響。就目前而言,這是最難預測的部分;雖然沒有任何公司能完全免於關稅效應,但我相信我們所服務的醫療科技、國防與工業領域,將相對能隔離於關稅衝擊之外。
Let me explain a bit. The applications that our products serve in the MedTech market have traditionally been considered essential. Our capacitors are in implantable devices, imaging, and ventilators, to name a few. Hearing aids have also been considered essential devices.
我稍作說明。我們產品在醫療科技市場所服務的應用,傳統上被視為必需品。例如,我們的電容器用於植入式裝置、影像設備與呼吸器等。助聽器也一直被視為必需裝置。
Our historical experience shows economic shocks and subsequent recessions can have modest short-term impacts on these markets but tend to have very little impact over across the course of a year. I also believe that the Defense programs we participate in are secure. In the past, the air filters and capacitors that we sell in the Defense space have generally been insulated from economic downturns.
我們的歷史經驗顯示,經濟衝擊及隨後的衰退,可能對這些市場造成溫和的短期影響,但在一整年的時間尺度上通常影響很小。我也相信我們參與的國防專案是穩健的。過去,我們在國防領域銷售的空氣濾網與電容器,一般而言也能免受景氣下行的影響。
Lastly, in the Industrial market, it is and has been more sensitive than MedTech and Defense to recessions, but we are not currently seeing any impact on demand. We are obviously monitoring this closely, as this could change based on the macroeconomic environment.
最後,在工業市場方面,相較於醫療科技與國防,它過去及目前對衰退更為敏感,但我們目前尚未看到需求受到任何影響。我們當然會密切監控,因為這可能會隨總體經濟環境而改變。
Now I'll turn to our results. We started 2025 on solid footing in Q1, delivering revenue of $132 million at the high end of our guided range. EPS of $0.18 was at the midpoint of the guided range, and we delivered cash from operations exceeding the high end of the guided range.
接下來談我們的業績。2025 年第一季我們以穩健態勢開局,營收達 1.32 億美元,位於我們指引區間的高端。每股盈餘(EPS)0.18 美元位於指引區間的中點,而我們的營運現金流也超過指引區間的高端。
Turning to our segments in Q1, MedTech and Specialty Audio revenue was $60 million, up slightly on a year over year basis and seasonally down from Q4. Hearing health revenue was seasonally down, which was offset by strength in our Specialty Audio business and our supply of metal cans in connection with the sale of the consumer MEMS Microphone business. As it relates to the current tariff environment, our historical experience shows that during times of economic uncertainty, there's often a short-term decline followed by a rebound in demand in our hearing health business.
就第一季各事業部而言,醫療科技與專業音訊(MedTech and Specialty Audio)營收為 6,000 萬美元,年增小幅上升,且因季節性因素較第四季下滑。聽力健康(Hearing health)營收因季節性而下滑,但被我們專業音訊業務的強勁表現,以及與出售消費型 MEMS 麥克風業務相關的金屬外殼(metal cans)供應所抵銷。就目前關稅環境而言,我們的歷史經驗顯示,在經濟不確定時期,聽力健康業務的需求往往會先短期下滑,隨後反彈。
By the way of example, in 2000 during the dotcom bubble burst, in 2008 during the financial crisis, and in 2020 during COVID, the market contracted for one or two quarters in response to the economic uncertainty with demand returning quickly to normalized levels. This is evidenced by hearing health markets growing 2% to 3% annually over the last 20 years.
舉例來說,2000 年網路泡沫破裂、2008 年金融危機,以及 2020 年 COVID 期間,市場都因經濟不確定性而在一到兩季內收縮,但需求很快回到正常水準。這也反映在過去 20 年聽力健康市場每年約 2% 至 3% 的成長。
That all being said, our backlog for the MedTech and Specialty Audio segment for Q2 is strong. Our partnership with our customers is leading to continued innovations, to data solutions enhancing the performance of their products. This coupled with our strong performance in the Specialty Audio business and new opportunities utilizing core companies, competencies, and medical markets leads us to continue to believe in our ability to grow throughout 2025 with year-over-year revenue growth accelerating in the second quarter.
綜合以上所述,我們醫療科技與專業音訊事業部第二季的在手訂單(backlog)依然強勁。我們與客戶的合作正帶來持續創新,包括以資料解決方案提升其產品效能。再加上我們在專業音訊業務的強勁表現,以及運用核心公司能力與醫療市場的新機會,使我們持續相信 2025 年全年具備成長能力,且第二季的年對年營收成長將加速。
In the Precision Device segment, Q1 revenues was $73 million flat to Q4. This was expected while we continue to work through production challenges in our specialty film line. Progress is being made. Our new prototype production line is up and running, improving the production flow. Yields are improving, and I have confidence in the team to continue to incrementally improve shipments throughout the first half of the year with a larger ramp up coming in the second half of the year. We are well-positioned for growth in 2025 as the specialty film line grants to full production.
在精密裝置(Precision Device)事業部方面,第一季營收為 7,300 萬美元,與第四季持平。在我們持續解決特殊薄膜(specialty film)產線的生產挑戰之際,這樣的表現符合預期。目前已取得進展。我們新的原型生產線已啟動運轉,改善了生產流程。良率正在提升,我對團隊有信心,能在上半年持續逐步提升出貨量,並在下半年迎來更大幅度的爬坡。隨著特殊薄膜產線邁向全面量產,我們在 2025 年的成長布局良好。
Additionally, we have strong design and quoting activity, especially in MedTech, Defense, and EV markets with our ceramic capacitors. In 'Q1, bookings trends for Precision Device segment independent of our previously announced $75 million-plus energy order was strong for the second consecutive quarter. The booking strength was broad-based across most of our end markets as we believe inventory levels are normalizing.
此外,我們在設計導入與報價活動方面也相當強勁,特別是在醫療科技(MedTech)、國防與電動車(EV)市場,主要來自我們的陶瓷電容。在第一季(Q1),不含我們先前宣布的超過7,500萬美元能源訂單,精密裝置(Precision Device)事業部的接單趨勢已連續第二季維持強勁。我們的接單強度在多數終端市場均呈現廣泛成長,我們相信庫存水位正在正常化。
It's noteworthy that bookings and shipments to our distribution partners across all our capacitor products were favorable as we continue to see their inventory levels reducing. This gives me confidence in the Precision Device segment expected return to year-over-year growth in the second quarter of 2025.
值得注意的是,我們所有電容產品對通路合作夥伴的接單與出貨表現良好,因為我們持續看到他們的庫存水位正在下降。這讓我對精密裝置事業部在2025年第二季可望恢復年對年成長更具信心。
In the first quarter, we purchased $5 million in shares and reduced our debt level by $15 million as our cash generation from operations exceeds the high end of our giant range. We expect to generate robust cash from operations throughout 2025. This will allow us to continue to explore acquisition opportunities, buy back shares, and keep our debt at manageable levels.
第一季我們回購了500萬美元的股票,並將負債水位降低1,500萬美元,因為我們營運產生的現金流超出我們指引區間的上緣。我們預期在2025年全年都能產生強勁的營運現金流。這將使我們能持續評估併購機會、回購股票,並將負債維持在可控水準。
As we close out the first quarter of 2025, I'm excited about the opportunities we have in front of us. We continue to see strong design winds across our product portfolio, with distribution orders increasing and inventory levels normalizing in the Industrial markets, coupled with increasing backlog and demand for our products, I have greater confidence that we will see year-over-year growth for 2025.
在結束2025年第一季之際,我對眼前的機會感到振奮。我們持續在整體產品組合看到強勁的設計導入動能;同時工業市場的通路訂單增加、庫存水位正常化,再加上我們產品的在手訂單與需求提升,我更有信心2025年將呈現年對年成長。
On May 13, we will be hosting our Investor Day where we will have the opportunity to lay out our plans for future growth in detail. I'm excited you will have the opportunity to hear from several members of our senior leadership team as they will discuss our competitive advantages and why we win across the markets we serve.
5月13日,我們將舉辦投資人日(Investor Day),屆時將有機會詳細說明我們未來成長的規劃。我也很期待各位能聽到我們多位資深領導團隊成員的分享,他們將討論我們的競爭優勢,以及我們為何能在所服務的市場中勝出。
Now let me turn the call over to John to detail our quarterly results and provide our Q2 guidance.
接下來我把電話交給John,請他說明本季業績並提供第二季(Q2)指引。
John Anderson - Chief Financial Officer, Senior Vice President
John Anderson - Chief Financial Officer, Senior Vice President
Thanks, Jeff. We recorded fourth-quarter revenue of $132 million, down 1% from the year-ago period and at the high end of our guided range. EPS was $0.18 in the quarter, flat from the year-ago period and at the midpoint of our guidance range. In the MedTech and Specialty Audio segment, Q1 revenue was $60 million, up slightly compared with the year-ago period. Q1 gross margins were 48.7%, down 450 basis points versus a year-ago period.
謝謝,Jeff。我們第四季營收為1.32億美元,較去年同期下降1%,並落在我們指引區間的上緣。本季每股盈餘(EPS)為0.18美元,與去年同期持平,並位於我們指引區間的中點。在醫療科技與專業音訊(MedTech and Specialty Audio)事業部,第一季營收為6,000萬美元,較去年同期小幅成長。第一季毛利率為48.7%,較去年同期下降450個基點。
As part of our supply agreement with Syntiant, we produced and supply metal cans on a cost-plus basis which negatively impacted gross margins by nearly 200 basis points in the quarter. The remainder of the year-over-year decline in gross margin was driven by unfavorable customer mix and the absence of a one-time benefit, which was recorded in Q1 2024.
作為我們與Syntiant供應協議的一部分,我們以成本加成(cost-plus)方式生產並供應金屬外殼(metal cans),使本季毛利率受到近200個基點的負面影響。其餘的年對年毛利率下滑,主要來自不利的客戶組合,以及2024年第一季認列的一次性利益不再出現。
While the supply agreement with Syntiant is expected to continue through the remainder of 2025, we expect M&A gross margins to improve sequentially, driven by mixed improvements and higher capacity utilization, resulting in full-year gross margins in the low 50% range.
雖然與Syntiant的供應協議預期將持續至2025年剩餘期間,我們預期醫療科技與專業音訊(M&A)事業部毛利率將逐季改善,主要由產品組合改善與產能利用率提升所帶動,進而使全年毛利率落在50%出頭(low 50%)的區間。
The Precision Devices segment delivered first-quarter revenues of $73 million, down 2% from the year-ago period and slightly above our expectations going into the quarter. Segment gross margins were 35.7%, flat from the first quarter of 2024, as factory productivity improvements in our legacy Precision Device business were partially offset by factory inefficiencies as we ramp up the specialty film product line.
精密裝置(Precision Devices)事業部第一季營收為7,300萬美元,較去年同期下降2%,且略高於我們在季初的預期。事業部毛利率為35.7%,與2024年第一季持平;主因我們既有精密裝置業務的工廠生產力改善,部分被我們在擴產特殊薄膜(specialty film)產品線過程中的工廠效率不彰所抵銷。
On a total-company basis, R&D expense in the quarter was $8 million, flat with Q1 2024 levels. SG&A expenses were $25 million, down $2 million from prior levels driven by cost reduction actions taken to right-size spending in connection with the sale of the consumer microphone business. Interest expense was $3 million in the quarter and down $2 million from the year-ago period as we continue to reduce our debt levels.
以全公司口徑來看,本季研發(R&D)費用為800萬美元,與2024年第一季持平。銷售、一般及行政(SG&A)費用為2,500萬美元,較先前水準減少200萬美元,主要因我們在出售消費型麥克風業務後,採取成本削減措施以使支出規模更為適當。本季利息費用為300萬美元,較去年同期減少200萬美元,因為我們持續降低負債水位。
Now I'll turn to our balance sheet and cash flow. In the first quarter, we generated $1 million in cash from operating activities exceeding the high end of our guided range driven by higher-than-expected customer prepayments. It is important to note that cash from operations for the three months ended March 31 includes $21 million in cash used to settle supplier obligations related to the consumer MEMS Microphone business which was sold last year. Capital spending was $4 million in the quarter.
接著說明資產負債表與現金流。第一季我們由營運活動產生100萬美元現金,超出我們指引區間的上緣,主要受惠於客戶預付款高於預期。需要特別說明的是,截至3月31日止三個月的營運現金流,包含用於清償與去年出售之消費型MEMS麥克風業務相關供應商義務的2,100萬美元現金支出。本季資本支出為400萬美元。
During the first quarter, we repurchased 300,000 shares at a total cost of $5 million and reduced outstanding borrowings under our revolving credit facility by $15 million. We exited the quarter with cash of $102 million and $189 million of debt that includes borrowings under our revolving credit facility and an interest-free seller note issued in connection with the Cornell acquisition.
第一季期間,我們以總成本500萬美元回購30萬股股票,並將循環信用額度(revolving credit facility)項下的未償借款減少1,500萬美元。本季末我們持有現金1.02億美元,負債為1.89億美元,其中包含循環信用額度借款,以及與Cornell收購案相關所開立的無息賣方票據(interest-free seller note)。
Lastly, our net leverage ratio based on trailing 12-months adjusted EBITDA was 0.7 times, and we have liquidity in excess of $350 million as measured by cash on hand plus unused capacity under our revolving credit facility.
最後,以過去12個月調整後EBITDA計算的淨槓桿比率為0.7倍;以手上現金加上循環信用額度未動用額度衡量,我們的流動性超過3.5億美元。
Moving to our guidance. For the second-quarter of 2025, revenues are expected to be between $135 million and $145 million. R&D expenses are expected to be between $8 million and $10 million. Selling at administrative expenses are expected to be within the range of $23 million to $25 million. We're projecting adjusted EBIT margin for the quarter to be within a range of 19% to 21%. Interest expense in Q2 is estimated at $3 million and includes non-cash imputed interest. We expect an effective tax rate of 13% to 17%.
接著談指引。2025年第二季營收預期介於1.35億至1.45億美元。研發費用預期介於800萬至1,000萬美元。銷售與行政費用預期落在2,300萬至2,500萬美元區間。我們預估本季調整後EBIT利潤率介於19%至21%。第二季利息費用估計為300萬美元,並包含非現金的推算利息(imputed interest)。我們預期有效稅率為13%至17%。
We're projecting EPS to be within a range of $0.21 to $0.25 per share. This assumes weighted average shares outstanding during the quarter of 90.1 million on a fully diluted basis. We're projecting cash generated by operating activities to be within the range of $10 million to $20 million which includes $9 million to settle supplier obligations related to consumer MEMS Microphone business. Capital spending is expected to be $7 million. We expect full-year capital spending to be 5% of revenues as we increase our investments associated with capacity expansion relating to our specialty film line.
我們預估每股盈餘(EPS)介於每股0.21至0.25美元。此假設本季完全稀釋後加權平均流通股數為9,010萬股。我們預估由營運活動產生的現金介於1,000萬至2,000萬美元,其中包含9,000萬美元用於清償與消費型MEMS麥克風業務相關的供應商義務。資本支出預期為700萬美元。隨著我們加大與特殊薄膜產線產能擴充相關的投資,我們預期全年資本支出將為營收的5%。
In conclusion, based on increasing order activity and our growing backlog, we expect to resume year-over-year revenue and earnings growth in the second quarter. Additionally, we expect another year of strong cash generation in 2025.
總結來說,基於訂單活動增加以及在手訂單持續成長,我們預期將在第二季恢復營收與獲利的年對年成長。此外,我們也預期2025年將再度呈現強勁的現金創造能力。
With that, we'll move to the Q&A portion of the call.
接下來,我們進入問答(Q&A)環節。
Operator
Operator
Thank you, sir. (Operator Instructions)
謝謝您,先生。(接線員指示)
Bob Labick, CJS Securities.
Bob Labick,CJS Securities。
Bob Labick - Analyst
Bob Labick - Analyst
Good afternoon. Thanks for taking our questions.
下午好。謝謝讓我們提問。
Jeffrey Niew - President, Chief Executive Officer, Director
Jeffrey Niew - President, Chief Executive Officer, Director
Hey Bob. We can barely hear you, Bob.
嗨,Bob。Bob,我們幾乎聽不到你的聲音。
Bob Labick - Analyst
Bob Labick - Analyst
Okay, great, sorry about that. Thank you. Well, first, congrats on nice quarter and obviously a good outlook as well. I think you know you hit a really important part with the minimal tariff exposure. I appreciate that color, the 5% direct and 3% kind of indirect, just sticking on the theme for a minute though.
好的,太好了,抱歉剛剛那樣。謝謝。首先,恭喜本季表現不錯,而且顯然展望也很好。我想你也知道,你提到關稅曝險很低這點非常重要。我很感謝你提供的細節:直接約5%、間接約3%;不過我想先沿著這個主題再追問一下。
Maybe talk about your -- you talked a little bit about MedTech. But overall, end-market customer exposure, how are you thinking about that? What are you hearing from your customers in this uncertain time right now around their outlooks and how it may impact you in the back half of this year?
也許談談你們的——你剛才稍微提到醫療科技(MedTech)。但整體而言,對終端市場客戶的曝險,你們是怎麼思考的?在目前這段不確定的時期,你們從客戶那邊聽到什麼關於他們展望的看法,以及這可能如何影響你們今年下半年?
Jeffrey Niew - President, Chief Executive Officer, Director
Jeffrey Niew - President, Chief Executive Officer, Director
Yeah, so first I would say, Bob, as I kind of said, we've not seen any change in demand. In fact, obviously our expectations for Q2 are incrementally higher than they say were a quarter ago for Q2. I don't think any of this, we've been kind of debating. We talked to a number of customers this pull forward. I don't think it is. A lot of our product is custom, a lot of new designs, especially in MedTech and Defense.
是的,所以首先我會說,Bob,正如我剛才提到的,我們沒有看到需求有任何變化。事實上,很明顯地,我們對第二季的預期,比起一季前對第二季的看法又略為提高。我不認為這些情況——我們一直在討論。我們也和多位客戶談過這種提前拉貨(pull forward)。我不認為是這樣。我們很多產品是客製化的,很多是新設計,尤其是在醫療科技(MedTech)與國防領域。
So I think in the MedTech space, let me take that first. I think if you think about most of the devices we sell to, they're essential devices and maybe you can, like with COVID, put off a medical device for a quarter, but ultimately if you need a pacemaker, you need a pacemaker, right? And I think this falls in the same category.
所以我想在醫療科技領域,我先談這個。我想如果你去想我們所供應的大多數裝置,它們都是必要裝置;也許像 COVID 那樣,你可以把某個醫療裝置延後一季,但最終如果你需要心律調節器(pacemaker),你就需要心律調節器,對吧?我認為這也屬於同一類。
A large percentage of hearing aids are sold are actually customers that already have them, and they need new ones because they're either very old or they're not working anymore and you become reliant. You know you need hearing aids to have either moderate to severe hearing loss, you're going to go by your hearing aids. So generally speaking, Bob, I don't think we see that there's a lot of exposure.
助聽器銷售中有很大一部分其實是既有使用者,他們需要換新,因為原本的要嘛很舊、要嘛已經不能用了,而你會變得依賴它。你知道,若你需要助聽器,代表你有中度到重度的聽力損失,你就會去買你的助聽器。所以整體而言,Bob,我不認為我們看到有很大的曝險。
Defense, I think most of the programs we're on are very insulated. We're not seeing any change in our Defense. Now that being said, I think the one area that we do probably have a little bit more exposure like generally is Industrial.
國防方面,我認為我們參與的大多數專案都非常具有隔離性(insulated)。我們沒有看到國防業務有任何變化。不過話說回來,我認為我們可能相對有一點點較多曝險的領域,一般來說是工業(Industrial)。
Now, here's what I would say about that. I've talked over the last few quarters about the inventory levels at our distributors which service the majority of our Industrial customers. Two quarters ago, I was talking about there were 6 months of inventory, then I said there was 4 to 5, then I said 4, 4.5. We're seeing that inventory now level gets to the 3- to 3.5-month level, which is normalized inventory and we're starting to see, again because of that, an increase in order activity because as they see the demand, they're going to start falling into a dangerously low position on inventory.
那麼,關於這點我會這麼說。過去幾季我一直在談我們經銷商的庫存水位,這些經銷商服務了我們大多數的工業客戶。兩季前我說有 6 個月的庫存,接著我說是 4 到 5 個月,然後我說 4、4.5 個月。我們現在看到庫存水位降到約 3 到 3.5 個月,這是正常化的庫存水準;而我們也開始看到——同樣因為這個原因——訂單活動增加,因為當他們看到需求時,他們的庫存就會開始落入一個危險偏低的位置。
So I think from our perspective, right now as we look through the rest of the year, we feel pretty good right now about the rest of the year. Now, all things being said, somebody could wake up tomorrow there could be something new, but the way the tariffs are today and how it's impacting our business, it feels like there's like very minimal impact to us right now.
所以從我們的角度來看,目前我們展望今年剩餘時間,我們對今年其餘時間的看法相當不錯。當然,話雖如此,明天可能有人醒來就會有新的事情發生;但以目前的關稅狀況以及它對我們業務的影響來看,感覺目前對我們的影響非常有限。
Bob Labick - Analyst
Bob Labick - Analyst
Okay, great, appreciate the extra color. That's wonderful.
好的,很棒,感謝補充更多細節。這很有幫助。
And then in terms of the growth drivers of the business, obviously you have this you talked about last quarter, the $75 million-plus capacitor order starting next year into an energy end market. Any updates or any changes and any impact from that since it's a little bit vague to us from the macro environment or is that still strong and you're confident in that as well?
另外就業務成長動能而言,很明顯你們在上季提到,從明年開始有一筆超過 7,500 萬美元的電容器訂單,將出貨到能源終端市場。這方面有任何更新或變動嗎?以及在目前宏觀環境下,這對該訂單是否有任何影響——因為對我們來說還有點模糊——還是說它依然強勁,你們也同樣有信心?
Jeffrey Niew - President, Chief Executive Officer, Director
Jeffrey Niew - President, Chief Executive Officer, Director
Well, I mean, we received a pretty substantial prepayment in the first quarter which drove our cash flow to be above the high end of the guided range. So this customer is fully committed and we don't see any impact on delivery starting in 2026. I think we've said in the past, expect something in the neighborhood of about $25 million of shipments on that order in 2026.
嗯,我是說,我們在第一季收到了一筆相當可觀的預付款,這使得我們的現金流高於指引區間的上緣。所以這位客戶是完全承諾的,我們也沒有看到對 2026 年開始交付有任何影響。我想我們過去也說過,預期 2026 年在這筆訂單上的出貨金額大約在 2,500 萬美元左右。
Bob Labick - Analyst
Bob Labick - Analyst
Super. All right, I will jump back in queue. Thank you.
太好了。好,那我回到隊列裡。謝謝。
Operator
Operator
Anthony Stoss, Craig-Hallum Capital Group.
Anthony Stoss,Craig-Hallum Capital Group。
Anthony Stoss - Analyst
Anthony Stoss - Analyst
Hey, guys, nice results. Let me just get a housekeeping one out of the way. John, can you, maybe I missed it, can you talk about kind of gross margin trajectory starting with Q2 and where you think it ends up in Q4?
嗨,各位,成績不錯。我先問一個例行性的問題。John,你能不能——也許我漏聽了——談一下毛利率走勢,從第二季開始,以及你認為到第四季會落在哪裡?
John Anderson - Chief Financial Officer, Senior Vice President
John Anderson - Chief Financial Officer, Senior Vice President
Yeah, Tony, you're talking about for the total business, total company?
可以,Tony,你是指整體業務、整家公司嗎?
Anthony Stoss - Analyst
Anthony Stoss - Analyst
Yes. Total company. Yes.
是的。整家公司。是。
John Anderson - Chief Financial Officer, Senior Vice President
John Anderson - Chief Financial Officer, Senior Vice President
Yeah. So if you think about the results that we just issued just above -- just slightly above 41% in gross margins, we're going to see pretty significant sequential improvement in that and you really have to look business by business, but the main drivers are going to be, again with demand moving up, our capacity utilization is going to improve both in the PD business as well as the MSA business. Both are increasing capacity.
是的。所以如果你看我們剛公布的結果,毛利率略高於 41%——稍微高於 41%。我們將會看到相當顯著的季對季改善;而你確實需要逐個事業來看,但主要驅動因素會是:同樣地,隨著需求上升,我們的產能利用率會改善,包含 PD 業務以及 MSA 業務。兩者都在提升產能。
In addition, there's some mixed improvement that is going to benefit us going into -- beginning in Q2. And really, we expect sequential improvement. Jeff mentioned this, we expect a stronger, given the uncertainty out there, we still expect a stronger back half and front half and again that's going to drive sequential -- expected to drive sequential gross margini improvement throughout 2025.
此外,產品組合也會有一些改善,將在第二季開始帶來助益。而且我們確實預期會逐季改善。Jeff 提到過這點:儘管外部仍有不確定性,我們仍預期下半年會比上半年更強,而這也將推動——預期將推動——2025 年全年毛利率逐季改善。
Jeffrey Niew - President, Chief Executive Officer, Director
Jeffrey Niew - President, Chief Executive Officer, Director
Yeah. I just want to add one piece, I think we've talked about this in the past, Tony, about how capacity utilization has been really a hold back, especially in the Precision Device area, in terms of gross margin over the last year, year and a half. And we're starting to see that start to dissipate as the demand is coming back.
是的。我只想補充一點:Tony,我想我們過去談過,產能利用率一直是拖累因素,尤其是在精密裝置(Precision Device)領域,過去一年到一年半對毛利率造成壓力。而隨著需求回升,我們開始看到這個影響逐漸消退。
I didn't mention this in the prepared remarks, but the book to bill for Precision Devices was above 1.15 in Q1. I mean it was strong. We had very, very strong orders for Precision Devices and that's, of course, not counting the $75 million energy order.
我在事先準備的講稿裡沒有提到,但精密裝置在第一季的接單出貨比(book-to-bill)高於 1.15。我的意思是,表現很強。我們在精密裝置拿到非常、非常強勁的訂單,當然這還不包含那筆 7,500 萬美元的能源訂單。
Anthony Stoss - Analyst
Anthony Stoss - Analyst
Right, can you give us like a range exit, gross margin to a company in Q4.
了解,你能不能給我們一個區間,第四季公司層級的毛利率在年底退出(exit)時大概是多少?
John Anderson - Chief Financial Officer, Senior Vice President
John Anderson - Chief Financial Officer, Senior Vice President
I would say 45% to 47% as we exit the year in gross margin.
我會說,年底退出時的毛利率大約在 45% 到 47%。
Anthony Stoss - Analyst
Anthony Stoss - Analyst
Perfect. And for you, Jeff, I mean, it's awesome that most of your production of PD is in the US. Do you think you might be able to pick up share from some of your competitors that don't produce much in the US. I'm just curious your thoughts, how do you think the rest of the year plays out. Are you seeing the inbound calls? Anything would be helpful.
完美。另外 Jeff,嗯,你們 PD 的大部分生產都在美國,這點很棒。你覺得你們是否可能從一些競爭對手那裡拿到市占——那些競爭對手在美國生產不多。我只是好奇你的想法,你覺得今年剩下時間會怎麼發展?你們有看到客戶主動來電嗎?任何資訊都會很有幫助。
Jeffrey Niew - President, Chief Executive Officer, Director
Jeffrey Niew - President, Chief Executive Officer, Director
Tony, I'm saving that for the next call, but I'll give you a little color here. Here's the situation, I think, with the dynamic and bottle nature of what's going on, I'm a little hesitant to start putting that out there to say yes, but we are definitely getting calls that says, okay, with these tariffs, normally we had said -- we had walked away from some of these bit lower-margin businesses like and now they're saying maybe we should consider buying with you and it's also security supply. And so it would primarily really in the like in more in the Industrial space than MedTech or Defense.
Tony,我把那個留到下一次電話會議再講,不過我先給你一些補充。目前的情況是:我認為在現在這種變動性很高、而且有點像「瓶頸」的狀態下,我有點猶豫直接對外說「是」,但我們確實接到一些電話,內容是:好,因為這些關稅,以前我們曾經——我們曾經退出一些毛利較低的業務——而現在他們在說,也許我們應該考慮向你們採購,另外也涉及供應安全(security of supply)。而這主要會發生在工業領域,而不是醫療科技或國防。
I mean, I don't think we're seeing anything like that. But in the Industrial space, we're definitely seeing a number of customers initiate conversations with us. It's more than a handful and saying, okay, we should start having some discussions. I want to see how this all plays out over the next quarter, but that definitely could be an upside in the back half of the year that's not factored into what we're saying today.
我的意思是,我不認為我們在其他領域看到類似情況。但在工業領域,我們確實看到不少客戶主動與我們展開對話。不只是一小撮,他們在說:好,我們應該開始談一談。我想先看看接下來一季整體會怎麼發展,但這確實可能成為今年下半年的上行空間,而這部分目前還沒有納入我們今天所說的內容之中。
Anthony Stoss - Analyst
Anthony Stoss - Analyst
That's really good news. I would lock them in a long-term supply agreements, get them down quick. Thanks. Great execution, guys. I'll jump back in queue.
那真是非常好的消息。我會把它們鎖定在長期供應協議裡,盡快把條件談下來。謝謝。各位執行得很棒。我先回到排隊等候。
John Anderson - Chief Financial Officer, Senior Vice President
John Anderson - Chief Financial Officer, Senior Vice President
Thanks, Tony.
謝謝你,Tony。
Operator
Operator
(Operator Instructions)
(接線員指示)
Christopher Rolland, Susquehanna.
Susquehanna 的 Christopher Rolland。
Christopher Rolland - Analyst
Christopher Rolland - Analyst
Hey, guys, congrats on the results.
嗨,各位,恭喜這次的業績表現。
So my question is if you could perhaps add some commentary around bookings, that's the book to bill above 1.5 is pretty incredible for PD. So what are we seeing for the back half? Are these really starting to fill out now. And then perhaps associated with that, I saw receivables were up. Does that kind of speak to the linearity in the quarter? Would you just describe things as kind of accelerating?
我的問題是,能否請你們就訂單(bookings)多補充一些評論;PD 的訂單出貨比(book-to-bill)高於 1.5 真的相當驚人。那麼我們在下半年會看到什麼?這些現在真的開始逐步填滿了嗎?另外可能相關的是,我看到應收帳款上升。這是否某種程度反映了本季的線性(linarity)?你們會把情況描述為正在加速嗎?
Jeffrey Niew - President, Chief Executive Officer, Director
Jeffrey Niew - President, Chief Executive Officer, Director
I'll let John do a little checking on the receivables, but for a minute just to be clear, the bookings were above 1.15.
我先讓 John 稍微確認一下應收帳款的部分,不過先澄清一下,訂單出貨比是高於 1.15。
Christopher Rolland - Analyst
Christopher Rolland - Analyst
1.15. Okay, I thought I heard 1.5. Okay, yeah, 1.15.
1.15。好,我以為我聽到的是 1.5。好,對,是 1.15。
Jeffrey Niew - President, Chief Executive Officer, Director
Jeffrey Niew - President, Chief Executive Officer, Director
But not counting the $75 million-plus order we received from energy, right? So if you could count that, the book to the bill would be a crazy number. So we tried to -- but it was pretty broad-based in PD, across our capacitor products, filters, and both the legacy PD business as well as, formerly, the Cornell business. So it's been pretty broad-based.
而且還不包含我們從能源端收到的那筆超過 7,500 萬美元的訂單,對吧?所以如果把那筆算進去,訂單出貨比會是個非常誇張的數字。所以我們試著——但 PD 這邊其實相當廣泛,涵蓋我們的電容產品、濾波器,以及既有的 PD 業務,還有先前的 Cornell 業務。所以是相當廣泛的。
I think, as I kind of said, what was most encouraging in the quarter is to see another step down of inventory at the distributors where it's now getting -- we're starting to see that demand is going up, inventory is coming down. So we're getting very close to what I would sit there and say is like there's risk and that's why we're seeing more orders from distributors because they're starting to say their inventories are going to start falling below where they feel comfortable and, hence, why we're getting strong bookings there.
我想,正如我提到的,本季最令人鼓舞的是看到通路經銷商的庫存又往下走了一步,現在正逐漸——我們開始看到需求上升、庫存下降。所以我們非常接近我會說的那種「有風險」的狀態;這也是為什麼我們看到經銷商下更多訂單,因為他們開始覺得庫存將會降到低於他們覺得舒適的水位,因此我們在那邊看到強勁的接單。
I would also add, beyond the distributors -- and we'll talk more about some of the applications at the Investor Day, but we have a lot of new products from specialty film, a lot of new products go in production. So very good -- that's very all-positive PD. The second piece, I would just talk about MSA, MedTech and Specialty Audio. We expect pretty strong sequential and year-over-year growth in Q2. And it's driven by -- and the customer mix should be a little bit better in Q2.
我也想補充,除了經銷商之外——我們會在投資人日更深入談一些應用,但我們在特種薄膜(specialty film)方面有很多新產品,許多新產品也開始進入量產。所以這對 PD 來說都是非常正面的。第二部分我想談 MSA、MedTech 與 Specialty Audio。我們預期第二季(Q2)無論是季增或年增都會相當強勁。而這主要是由——而且第二季的客戶組合應該會稍微更好一些。
We talked about it kind of impacting the gross margins a little bit, but it should be better the customer mix in Q2. So I think, I want to be cautious here. But, Chris, but right now if I look through the year and a lot of the orders we're getting, especially in MedTech and Defense, they're not orders like these are not turns orders like we get an order to deliver it, and you're done. These are orders that are being booked for the rest of the year and so we feel pretty good about the full year.
我們提過這可能會對毛利率有一些影響,但第二季的客戶組合應該會更好。所以我想在這裡要保持審慎。不過,Chris,就目前我看整年度以及我們拿到的許多訂單,特別是在 MedTech 與國防領域,這些不是那種「急單」(turns orders),也就是接到單、交付完就結束。這些是已經為今年剩餘期間所預訂的訂單,因此我們對全年感覺相當不錯。
John Anderson - Chief Financial Officer, Senior Vice President
John Anderson - Chief Financial Officer, Senior Vice President
Yeah, kind of the same question, question on receivables. Nothing unusual here; it's just timing of customer collections. Our receivables were, at the end of Q1, kind of flat with 12.31, but you're right, they were up a fair amount from March 31, 2024. And again, nothing special. It's not like we're having collection issues or anything. It's just timing of payments. We have some customers, larger customers that have 3.31 year-ends. Sometimes they pay before either year-end, sometimes it slips into Q2, but nothing alarming there.
對,應收帳款的問題大致相同。這裡沒有什麼不尋常;只是客戶收款時點的問題。我們在第一季末的應收帳款相較於 12/31 大致持平,但你說得對,和 2024 年 3 月 31 日相比確實增加不少。同樣地,沒有什麼特別的原因。並不是我們有收款問題之類的。就只是付款時點。我們有一些較大的客戶是 3/31 為會計年度結束。有時他們會在年末前付款,有時會延到第二季,但沒有任何令人擔憂的地方。
Christopher Rolland - Analyst
Christopher Rolland - Analyst
Excellent, and I do not want to steal any thunder from the Analyst Day, but it seems like the business is solidifying. So I was wondering kind of what's next for Knowles, like how much focus is there on inorganic growth opportunities like in new product segments. And then how much opportunity or how much of your focus is spent on inorganic opportunities outside of the company.
很好,我也不想搶走分析師日的風采,但看起來業務正在更趨穩固。所以我想問 Knowles 接下來的方向是什麼:你們對於非有機成長機會(例如新產品領域)的關注度有多高?另外,你們有多少機會或多少重點放在公司外部的非有機機會上?
Jeffrey Niew - President, Chief Executive Officer, Director
Jeffrey Niew - President, Chief Executive Officer, Director
Yeah, I think that's really good question, Chris. First, let me talk about the organic opportunities. Each one of our business unit leaders who will be presenting are going to go into these opportunities that they have over the next one, two, three years of where growth could come from. So they're all going to do that.
是的,Chris,我覺得這是個很好的問題。首先我先談有機成長機會。我們每一位事業單位負責人都會在簡報中深入說明他們在未來一到兩到三年有哪些機會、成長可能來自哪裡。所以他們都會談到。
On the inorganic side, we are going to have, I don't know if we've announced the officially the presenters list, but our Head of Corporate Development is going to be presenting at the Investor Day and to talk about our inorganic opportunities. I would sit there and say, and he would probably our guy who does this, said a pretty significant portion of his time during the Cornell acquisition was also dedicated towards the divestiture of the consumer MEMS Microphone business.
在非有機方面,我不確定我們是否已正式公布講者名單,但我們的企業發展主管會在投資人日進行簡報,談我們的非有機機會。我會說——而他大概也會這麼說——在 Cornell 併購期間,他相當大一部分時間也投入在消費性 MEMS 麥克風業務的剝離(divestiture)上。
He's freed up now to spend more time with his team on inorganic opportunities. And I think I want to caution right now, like with the market the way it is, I think things are -- like a lot of people are pausing on M&A right now. I'm glad our balance sheet looks great. We're in a great position, but you know we're ready when the right opportunity comes along to move that forward. And we're going to go into more detail about what we're looking for, and you know the kind of metrics we're looking for, the type of products. We'll go into more detail on that at the Investor Day.
他現在已經騰出時間,可以和他的團隊花更多時間在非有機機會上。但我想先提醒一下,以目前市場狀況來看,我覺得很多人現在都在暫緩併購(M&A)。我很高興我們的資產負債表看起來非常強健。我們處在很好的位置;但你知道,當合適的機會出現時,我們已準備好推進。我們也會更詳細說明我們在尋找什麼,以及你知道,我們看重的指標、產品類型。我們會在投資人日更深入說明。
Christopher Rolland - Analyst
Christopher Rolland - Analyst
Fantastic. Thanks, Jeff, and congrats.
太棒了。謝謝你,Jeff,也再次恭喜。
Jeffrey Niew - President, Chief Executive Officer, Director
Jeffrey Niew - President, Chief Executive Officer, Director
Thanks.
謝謝。
Operator
Operator
At this time no one else has signaled. (Operator Instructions)
目前沒有其他人示意要提問。(接線員指示)
And at this time there are no (technical difficulty). That does conclude our question-and-answer session as well as our conference for today. We would like to thank you all for your participation. You may not disconnect.
目前沒有(技術問題)。今天的問答環節以及本次電話會議到此結束。感謝各位的參與。您現在可以掛線。